ArticleThe American journal of pathology2014

Targeting mitochondria-derived reactive oxygen species to reduce epithelial barrier dysfunction and colitis.

Arthur Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.